TNDM
Price
$12.19
Change
-$0.24 (-1.93%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
839.89M
42 days until earnings call
XRAY
Price
$13.43
Change
-$0.19 (-1.40%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
2.7B
43 days until earnings call
Interact to see
Advertisement

TNDM vs XRAY

Header iconTNDM vs XRAY Comparison
Open Charts TNDM vs XRAYBanner chart's image
Tandem Diabetes Care
Price$12.19
Change-$0.24 (-1.93%)
Volume$18.58K
Capitalization839.89M
DENTSPLY SIRONA
Price$13.43
Change-$0.19 (-1.40%)
Volume$36.74K
Capitalization2.7B
TNDM vs XRAY Comparison Chart in %
Loading...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TNDM vs. XRAY commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TNDM is a Hold and XRAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (TNDM: $12.43 vs. XRAY: $13.62)
Brand notoriety: TNDM and XRAY are both not notable
TNDM represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TNDM: 83% vs. XRAY: 82%
Market capitalization -- TNDM: $839.89M vs. XRAY: $2.7B
TNDM [@Medical/Nursing Services] is valued at $839.89M. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.7B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.06B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TNDM’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • TNDM’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TNDM’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • TNDM’s TA Score: 4 bullish, 3 bearish.
  • XRAY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both TNDM and XRAY are a good buy in the short-term.

Price Growth

TNDM (@Medical/Nursing Services) experienced а -1.04% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -2.08% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.66%. For the same industry, the average monthly price growth was +5.73%, and the average quarterly price growth was +6.96%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.23%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +7.18%.

Reported Earning Dates

TNDM is expected to report earnings on Oct 29, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+3.66% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.7B) has a higher market cap than TNDM($840M). XRAY YTD gains are higher at: -26.766 vs. TNDM (-65.491). TNDM has higher annual earnings (EBITDA): -179.69M vs. XRAY (-689M). XRAY has more cash in the bank: 359M vs. TNDM (315M). TNDM has less debt than XRAY: TNDM (449M) vs XRAY (2.49B). XRAY has higher revenues than TNDM: XRAY (3.67B) vs TNDM (1B).
TNDMXRAYTNDM / XRAY
Capitalization840M2.7B31%
EBITDA-179.69M-689M26%
Gain YTD-65.491-26.766245%
P/E RatioN/AN/A-
Revenue1B3.67B27%
Total Cash315M359M88%
Total Debt449M2.49B18%
FUNDAMENTALS RATINGS
TNDM vs XRAY: Fundamental Ratings
TNDM
XRAY
OUTLOOK RATING
1..100
1463
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
9386
SEASONALITY SCORE
1..100
5022

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for TNDM (99). This means that XRAY’s stock grew significantly faster than TNDM’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TNDM (100). This means that XRAY’s stock grew similarly to TNDM’s over the last 12 months.

XRAY's SMR Rating (97) in the Medical Specialties industry is in the same range as TNDM (99). This means that XRAY’s stock grew similarly to TNDM’s over the last 12 months.

XRAY's Price Growth Rating (64) in the Medical Specialties industry is in the same range as TNDM (65). This means that XRAY’s stock grew similarly to TNDM’s over the last 12 months.

XRAY's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as TNDM (93). This means that XRAY’s stock grew similarly to TNDM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TNDMXRAY
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 8 days ago
72%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KMVAX39.56N/A
N/A
Kirr Marbach Partners Value
VGIFX90.30N/A
N/A
JPMorgan US Value R5
SGQCX42.58N/A
N/A
DWS International Growth C
FGFLX45.19N/A
N/A
Federated Hermes Intl Leaders IS
PEGEX21.99N/A
N/A
PGIM Jennison Mid-Cap Growth R2

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+2.81%
TFX - TNDM
45%
Loosely correlated
-0.06%
SHC - TNDM
40%
Loosely correlated
+0.43%
AZTA - TNDM
39%
Loosely correlated
+2.17%
CLPT - TNDM
39%
Loosely correlated
+1.72%
A - TNDM
38%
Loosely correlated
+1.24%
More